abstract gray background

Archives: Resources

PPD | Video
Creating a Patient and Site-Centric Approach to Clinical Trials
  • External Link

Tap into insights on how to embrace a patient diversity mindset.

Watch
PPD | Webinar
Oncology Clinical Trials Webinar
  • External Link

Watch this webinar to learn more about how to solve complex challenges in oncology clinical trials using data-driven and innovative approaches.

Read More
PPD | Webinar
Implementation Science Webinar
  • External Link

Watch this webinar to learn how the emerging field of implementation science helps overcome new healthcare innovation challenges.

Watch this webinar to learn how the emerging field of implementation science helps overcome new healthcare innovation challenges
PPD | Report
Contract Pharma 2023 CRO Industry Report
  • External Link

Explore key insights, challenges and trends in the global CRO services market.

Read More
PPD | Article
Building a Strong Data Foundation for DCTs with an FSP Model
  • External Link

Access four key decision points critical for optimizing your decentralized trial.

Read More
PPD | Case Study
Conversion to a Sole-provider FSP Model
  • External Link

Learn how our FSP experts delivered process improvements that outperformed customer goals.

Learn how our FSP experts delivered process improvements that outperformed customer goals
PPD | Case Study
Case Study: How to Reduce Site Burden and Lab Data Queries Using Preclarus™
  • External Link

See how Preclarus enables more-informed decisions and significant resource and time savings.

Read More
PPD | Article
Defining Demographic Cohorts in Clinical Trial Populations
  • External Link

Learn how to achieve appropriate diversity in clinical trials by using real world data in this Contemporary Clinical Trial paper.

Read More
PPD | Article
Solving Challenges in Cell Therapy Clinical Trials & Effectively Delivering Complex Studies in Advanced Therapeutics
  • External Link

BioInsights interviews PPD immuno-oncology experts for their insights on overcoming key obstacles for developing cell therapies in oncology.

Read More